Amgen Inc. (AMGN) Q1 2012 Earnings Results

Amgen Beats on EPS, Stock Up 0.5%

Amgen's earnings report shows a solid performance with an EPS beat, which contributed to a 0.5% increase in stock price. The company did not provide revenue figures or future guidance, but management's positive tone suggests confidence in their ongoing strategies. Investors may view the EPS surprise as a sign of resilience in a competitive market.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.61	N/A	+12.75%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a positive outlook on the company's performance in core areas. They emphasized their commitment to innovation and growth.

Management highlighted strong performance in key therapeutic areas.

They noted ongoing investments in research and development.

Focus remains on maintaining market leadership despite competitive pressures.

Amgen Beats on EPS, Stock Up 0.5%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 0.5%

Key numbers

Management commentary